Showing results (71-80 of 118) with videos related to

Sort By:
Pageof 12
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|January 17, 2023
GATA3 Expression in Human Tumors: A Tissue Microarray Study on 16,557 TumorsViktor Reiswich, Carol E Schmidt, Maximilian Lennartz, et al.
Molecular and Cellular Endocrinology|November 11, 2023
Comparison of INSM1 immunostaining with established neuroendocrine markers synaptophysin and chromogranin A in over 14,000 neuroendocrine and non-neuroendocrine tumorsKatharina Möller, Ria Uhlig, Natalia Gorbokon, et al.
World Journal of Urology|November 21, 2019
Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancerSimon Kind, Franziska Büscheck, Doris Höflmayer, et al.
Pathology, Research and Practice|September 22, 2022
Diagnostic and prognostic role of pancreatic secretory granule membrane major glycoprotein 2 (GP2) immunohistochemistry: A TMA study on 27,681 tumorsRia Uhlig, Karin Günther, Nina Bröker, et al.
Biomedicines|October 27, 2022
Inhibin Alpha Expression in Human Tumors: A Tissue Microarray Study on 12,212 TumorsSören Weidemann, Nessar Ahmad Noori, Maximilian Lennartz, et al.
Pathology, Research and Practice|November 14, 2022
Desmoglein 3 (Dsg3) expression in cancer: A tissue microarray study on 15,869 tumorsFlorian Viehweger, Ahmad Azem, Natalia Gorbokon, et al.
Molecular Medicine (Cambridge, Mass.)|March 8, 2020
Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusionChristoph Fraune, Luisa Harms, Franziska Büscheck, et al.
Molecular Carcinogenesis|September 24, 2019
A shift from membranous and stromal syndecan-1 (CD138) expression to cytoplasmic CD138 expression is associated with poor prognosis in breast cancerSimon Kind, Annika Jaretzke, Franziska Büscheck, et al.
Archives of Pathology & Laboratory Medicine|August 2, 2022
SATB2 Expression in Human Tumors: A Tissue Microarray Study on More Than 15 000 TumorsDavid Dum, Daniela Kromm, Maximilian Lennartz, et al.
Annals of Diagnostic Pathology|August 23, 2021
Immunohistochemically detectable thyroglobulin expression in extrathyroidal cancer is 100% specific for thyroidal tumor originStefan Steurer, Jana Schneider, Franziska Büscheck, et al.
Pageof 12